Evidence map›Paper›PMID 40955679›Full record

ArticleNanoscale horizons2025

Proline stabilizes amphiphilic gold nanoparticles

Ting Mao, Quy Ong, Joachim Kohlbrecher, Ekaterina Poliukhina, Paulo Jacob Silva, Francesco Stellacci

Abstract read
In one paragraph

Article in Nanoscale horizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting MaoInstitute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. francesco.stellacci@epfl.ch.ORCID http://orcid.org/0000-0002-5710-0534
Quy OngInstitute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. francesco.stellacci@epfl.ch.ORCID http://orcid.org/0009-0002-2953-3559
Joachim KohlbrecherPSI Center for Neutron and Muon Sciences, Paul Scherrer Institute, Villigen PSI CH-5232, Switzerland.ORCID http://orcid.org/0000-0001-5879-6943
Ekaterina PoliukhinaInstitute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. francesco.stellacci@epfl.ch.ORCID http://orcid.org/0009-0001-7688-1049
Paulo Jacob SilvaInstitute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. francesco.stellacci@epfl.ch.ORCID http://orcid.org/0009-0009-2889-2454
Francesco StellacciInstitute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. francesco.stellacci@epfl.ch.ORCID http://orcid.org/0000-0003-4635-6080

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colloidal dispersions are key in many fields of science and technology. Recently, we have shown that small molecules can stabilize dispersions of nanoscale objects, such as proteins and nanoparticles by screening their net attractive interactions. This new effect is essentially the opposite of the well-known salt screening of electrostatic interaction. Here we show that small molecule stabilization of nanoparticles is a phenomenon strongly linked to the hydrophobic content of the particles as well as to the strength of their hydrophobic attraction. We compare the effect of proline on gold nanoparticles coated with 11-mercaptoundecane sulfonate (MUS) at varying percentages of the hydrophobic ligand octanethiol (OT). We show that the larger the percentage of OT, the larger the proline stabilization effect is. We also compare the effect of proline on water dispersions of nanoparticles with that on heavy water dispersions. In the latter, the hydrophobic effect plays a bigger role. We find that in D

Identifiers

PMID40955679
PMCPMC12439247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.